Next batch of CR% results????We don't know what the next batch of CR%(Complete Response) will be.
But we know this...
In the June 24,2022 PressRelease, Dr. Arkady Mandel said" The success in the Phase 1b NMIBC clinical study has led to the impressive preliminary results demonstrated in the Phase 11 NMIBC clinical study, focused primarily on efficacy and secondary on safety. In the future, I foresee great potential for Theralase Anti-cancer therapy (ACT) to deliver a safe and effective anti-cancer treatment for numerous cancer indications with high unmet needs".
Everyday we are getting closer & closer to these impressive results that will get TLT BTD(Break Through Designation).
Note1) Dr.Mandel is a scientist (Chief Scientific Officer of TLT), scientists have a tendency to be careful and more concervative when making predictions.
Note 2) Big Pharma are going to love "Numerous cancer indications with unmet needs"
Be ready for it, in the near future, events could unfold rapidly.